Literature DB >> 27134122

Recommendations for aetiological diagnosis of bronchiectasis.

.   

Abstract

The number of bronchiectasis diagnoses has increased in the last two decades due to several factors. Research carried out over the last years showed that an aetiological diagnosis could change the approach and treatment of a relevant percentage of patients and consequently the prognosis. Currently, systematic investigation into aetiology, particularly of those disorders that can be subject to specific treatment, is recommended. Given the complexity of the aetiological diagnosis, the Pulmonology Portuguese Society Bronchiectasis Study Group assembled a working group which prepared a document to guide and standardize the aetiologic investigation based on available literature and its own expertise. The goal is to facilitate the investigation, rationalize resources and improve the delivery of care, quality of life and prognosis of patients with bronchiectasis.
Copyright © 2016 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Aetiological diagnosis; Bronchiectasis; Recommendations

Mesh:

Year:  2016        PMID: 27134122     DOI: 10.1016/j.rppnen.2016.03.004

Source DB:  PubMed          Journal:  Rev Port Pneumol (2006)        ISSN: 0873-2159


  4 in total

Review 1.  When and how ruling out cystic fibrosis in adult patients with bronchiectasis.

Authors:  Andrea Gramegna; Stefano Aliberti; Manuela Seia; Luigi Porcaro; Vera Bianchi; Carlo Castellani; Paola Melotti; Claudio Sorio; Enza Consalvo; Elisa Franceschi; Francesco Amati; Martina Contarini; Michele Gaffuri; Luca Roncoroni; Barbara Vigone; Angela Bellofiore; Cesare Del Monaco; Martina Oriano; Leonardo Terranova; Maria Francesca Patria; Paola Marchisio; Baroukh M Assael; Francesco Blasi
Journal:  Multidiscip Respir Med       Date:  2018-08-09

Review 2.  Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis.

Authors:  Martina Contarini; Amelia Shoemark; Jessica Rademacher; Simon Finch; Andrea Gramegna; Michele Gaffuri; Luca Roncoroni; Manuela Seia; Felix C Ringshausen; Tobias Welte; Francesco Blasi; Stefano Aliberti; James D Chalmers
Journal:  Multidiscip Respir Med       Date:  2018-08-09

3.  Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis.

Authors:  Kaijun Zhang; Xin Zou; Zhiyi Ma; Xiaohong Liu; Chencheng Qiu; Lingyan Xie; Zhaosheng Lin; Saiyu Li; Yongming Wu
Journal:  Can Respir J       Date:  2022-03-09       Impact factor: 2.409

4.  Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement.

Authors:  Andrea Gramegna; Stefano Aliberti; Marco Confalonieri; Angelo Corsico; Luca Richeldi; Carlo Vancheri; Francesco Blasi
Journal:  Multidiscip Respir Med       Date:  2018-10-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.